Explore All 401 Growth Capital Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | December 1, 2003 |
| Target | Purna Pharma |
| Sector | Life Science |
| Investor(s) | Creafund |
| Deal Type | Growth Capital |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 300M EUR |
| Size | Middle-Market |
| Type | Sector Agnostic |
Creafund is a private holding company that looks to acquire majority stakes in mature Belgian companies. Creafund takes majority stakes of between €5 and €25m in Belgian SMEs, being companies with EBITDA of between €2.5m and €25m, alongside entrepreneurs, family shareholders, and management. Prospective transaction situations include growth capital financings, buyouts, and consolidations. Creafund was formed in 2001 and is based in Sint-Martens-Latem, Belgium.
| Deal Context for Investor | # |
|---|---|
| Overall | 1 of 13 |
| Sector: Life Science | 1 of 2 |
| Type: Growth Capital | 1 of 4 |
| Country: Belgium | 1 of 10 |
| Year: 2003 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-01-01 |
Beddeleem
Nazareth-De Pinte, Belgium Beddeleem specializes in design, manufacturing, and installation of fixed and moveable partition walls, system ceilings, door systems, project furniture, raised floors, and the total fit-out of office buildings. Beddeleem was established in 1950 and is headquartered in Nazareth-De Pinte, Belgium. |
Buy | - |
